← Back
Data updated: Mar 29, 2026
BRIGHT
MetabolicOncologyNeurology
Generics
BRIGHT is a generic drug manufacturer focused on Metabolic, Oncology, Neurology.
2023
Since
1
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 87%
0 drugs Phase 3: 4 Phase 2: 3 Phase 1: 4
Oncology 7%
0 drugs Phase 1: 2
Neurology 7%
0 drugs Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-09-01
- Latest
- 2023-09-01
- Applications
- 1